Exp Mol Med.  2008 Aug;40(4):427-434. 10.3858/emm.2008.40.4.427.

Gene transfer using liposome-complexed adenovirus seems to overcome limitations due to coxsackievirus and adenovirus receptor-deficiency of cancer cells, both in vitro and in vivo

Affiliations
  • 1Department of Internal Medicine, Dong-A University College of Medicine Busan, Korea.
  • 2Korea Human Resource Development, Institute for Health and Welfare, Seoul, Korea. hsh325@paran.com
  • 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • 4Department of Bioscience and Biotechnology, Sejong University, Seoul, Korea.
  • 5Department of Pathology and Medical Research Center for Cancer Molecular Therapy, Dong-A University College of Medicine, Busan, Korea. jsjung1@dau.ac.kr

Abstract

Use of adenoviruses as vehicle for gene therapy requires that target cells express appropriate receptors such as coxsakievirus and adenovirus receptor (CAR). We show here that CAR-deficiency in cancer cells, that limits adenoviral gene delivery, can be overcome by using adenovirus complexed with the liposome, Ad-PEGPE [1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(poly-ethylene glycol)-2000]. We first confirmed that CT-26 mouse colon cancer cells are deficient in CAR by RT-PCR, and then showed that CT-26 cells infected with Ad-GFP/PEGPE exhibited highly enhanced expression of green fluorescent protein (GFP), compared with those infected with Ad-GFP. GFP expression depends on the dose of liposome and adenovirus. Luciferase expression in livers treated with Ad-luc/PEGPE was about 1,000-fold less than those infected with Ad-luc. In a liver metastasis mouse tumor model developed by intrasplenic injection of CT-26 cells, luciferase expression following i.v. injection of Ad-luc/PEGPE was significantly higher in tumors than in adjacent non-neoplastic liver. Following systemic administration of Ad-GFP/PEGPE, GFP expression increased in tumors more than in adjacent liver while the reverse was true following administration of Ad-GFP. In the latter case, GFP expression was higher in liver than in tumors. This study demonstrates that systemic delivery of PEGPE-adenovirus complex is an effective tool of adenoviral delivery as it overcomes limitation due to CAR deficiency of target cells while reducing hepatic uptake and enhancing adenoviral gene expression in tumors.

Keyword

adenovirus; CXADR protein, human; gene therapy; gene transfer techniques; liposomes; models, animal

MeSH Terms

*Adenoviridae/genetics/metabolism
Animals
Colonic Neoplasms/*genetics/metabolism/pathology/*therapy
Dose-Response Relationship, Drug
Gene Therapy
*Gene Transfer Techniques
Genetic Vectors
Green Fluorescent Proteins/genetics
Liposomes/administration & dosage/chemistry/pharmacokinetics/*therapeutic use
Liver/drug effects/metabolism
Male
Mice
Mice, Inbred BALB C
Mice, Transgenic
NIH 3T3 Cells
Phosphatidylethanolamines/administration & dosage
Polyethylene Glycols/administration & dosage
Receptors, Cytoplasmic and Nuclear/deficiency/genetics
Receptors, Virus/deficiency/*genetics
Transcription Factors/deficiency/genetics
Tumor Cells, Cultured
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr